Richmond Brothers, Inc.
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 9, 2024), Richmond Brothers, Inc. reported 24 stock positions worth $54.0 million. Its top holding was Invesco QQQ Trust Series 1 (QQQ) at 34.5% of the portfolio, followed by Mimedx (MDXG, 15.7%) and Berkshire Hathaway Class B (BRK.B, 10.7%). Compared with Q4 2023, it opened 2 new positions, sold out of 1, added to 2 and reduced 17. The biggest buy was Guggenheim Strategic Opport (GOF, shares +2%) and the biggest sale Mimedx (MDXG, shares −22%).
- Most Recent 13F
- Q2 2026
- Location
- JACKSON, MI
- CIK
- 0001540462
- Portfolio Value
- $54.0M (Q1 2024)
- SEC Filing
- 0001085146-24-002357 ↗ filed May 9, 2024
Holdings Value
Holdings 24 stocks · $54.0M
| QQQ Invesco QQQ Trust Series 1 | 34.54% | 41,972 | $18.6M | Reduce -7.3% |
| MDXG Mimedx Group Inc. | 15.66% | 1,097,016 | $8.4M | Reduce -21.9% |
| BRK.B Berkshire Hathaway Inc. Class B | 10.67% | 13,693 | $5.8M | Reduce -7.1% |
| AAPL Apple Inc. | 9.58% | 30,139 | $5.2M | Reduce -7.9% |
| GOF Guggenheim Strategic Opport | 8.02% | 302,107 | $4.3M | Add +1.6% |
| MSFT Microsoft Corp. | 3.99% | 5,121 | $2.2M | Reduce -1.6% |
| ARKK ARK Innovation ETF | 2.94% | 31,639 | $1.6M | Reduce -7.4% |
| IBB iShares Biotechnology ETF | 2.10% | 8,249 | $1.1M | Reduce -11.2% |
| DRRX Durect Corporation | 1.72% | 768,344 | $930K | Add +48.2% |
| HRTX Heron Therapeutics Inc. | 1.52% | 296,706 | $822K | No change |
| NVG Nuveen Amt-FR Muni CRDT | 1.03% | 45,850 | $557K | Reduce -11.4% |
| RMTI Rockwell Medical Inc. | 0.99% | 322,251 | $535K | Reduce -21.9% |
| AMZN Amazon.com Inc. | 0.94% | 2,797 | $505K | Reduce -28.4% |
| IVV iShares Core S&P 500 ETF | 0.88% | 908 | $477K | Reduce -1.2% |
| IRD Opus Genetics Inc. filed as OCUPHIRE PHARMA INC | 0.85% | 227,461 | $457K | Reduce -10.0% |
| APLT Applied Therapeutics Inc. | 0.78% | 61,827 | $420K | Reduce -50.0% |
| TQQQ Proshares Ultrapro QQQ | 0.64% | 5,613 | $346K | New |
| AXONICS INC | 0.61% | 4,749 | $328K | No change |
| GOOG Alphabet Inc. Class C | 0.56% | 1,984 | $302K | Reduce -0.6% |
| MCD McDonald's Corp. | 0.50% | 948 | $267K | Reduce -21.1% |
| ONCT Oncternal Therapeutics Inc. | 0.41% | 24,696 | $222K | No change |
| PG The Procter & Gamble Co. | 0.39% | 1,293 | $210K | New |
| VZ Verizon Communications Inc. | 0.38% | 4,947 | $208K | Reduce -14.2% |
| AIRI Air Industries Group | 0.30% | 34,805 | $164K | Reduce -64.5% |
Portfolio Sells Q4 2023 → Q1 2024
| MDXG Mimedx Group Inc. | Reduce -21.9% | 15.66% | −5.81 |
| AAPL Apple Inc. | Reduce -7.9% | 9.58% | −1.41 |
| IRD Opus Genetics Inc. | Reduce -10.0% | 0.85% | −0.48 |
| RMTI Rockwell Medical Inc. | Reduce -21.9% | 0.99% | −0.37 |
| AIRI Air Industries Group | Reduce -64.5% | 0.30% | −0.25 |
| ARKK ARK Innovation ETF | Reduce -7.4% | 2.94% | −0.18 |
| MCD McDonald's Corp. | Reduce -21.1% | 0.50% | −0.13 |
| IBB iShares Biotechnology ETF | Reduce -11.2% | 2.10% | −0.10 |
| AMZN Amazon.com Inc. | Reduce -28.4% | 0.94% | −0.10 |
| NVG Nuveen Amt-FR Muni CRDT | Reduce -11.4% | 1.03% | −0.03 |
| CRGEQ Charge Enterprises Inc. | Sold out | 0.00% | −0.00 |
| VZ Verizon Communications Inc. | Reduce -14.2% | 0.38% | +0.01 |
| APLT Applied Therapeutics Inc. | Reduce -50.0% | 0.78% | +0.06 |
| GOOG Alphabet Inc. Class C | Reduce -0.6% | 0.56% | +0.07 |
| IVV iShares Core S&P 500 ETF | Reduce -1.2% | 0.88% | +0.12 |
| MSFT Microsoft Corp. | Reduce -1.6% | 3.99% | +0.58 |
| BRK.B Berkshire Hathaway Inc. Class B | Reduce -7.1% | 10.67% | +1.51 |
| QQQ Invesco QQQ Trust Series 1 | Reduce -7.3% | 34.54% | +2.23 |
Portfolio Buys Q4 2023 → Q1 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 96 | $192.3M | QQQ, AAPL, NVDA, MSFT, VGT |
| Q1 2026 | 36 | $150.2M | QQQ, VDE, VPU, VAW, VIS |
| Q4 2025 | 36 | $157.2M | QQQ, VOX, VHT, VGT, VFH |
| Q3 2025 | 34 | $158.4M | QQQ, VOX, VPU, VGT, BSV |
| Q2 2025 | 30 | $152.7M | QQQ, BSV, BIV, VPU, VOX |
| Q1 2025 | 31 | $158.2M | BSV, BIV, VTIP, QQQ, BIL |
| Q4 2024 | 32 | $156.0M | QQQ, BIL, VOX, VCR, VFH |
| Q3 2024 | 33 | $162.2M | QQQ, BIL, VPU, VOX, VIS |
| Q2 2024 | 22 | $50.6M | QQQ, MDXG, AAPL, BRK.B, GOF |
| Q1 2024 | 24 | $54.0M | QQQ, MDXG, BRK.B, AAPL, GOF |